首页> Cancer letters> K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xuehui,Wang

第一单位： Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China; Institute of Breast Disease, School of Medicine, Tongji University, China.

作者： Xuehui,Wang ^[1] ; Xiaochong,Deng ^[2] ; Jiashu,Hu ^[1] ; Wenfang,Zheng ^[2] ; Danrong,Ye ^[2] ; Xiqian,Zhou ^[2] ; Lin,Fang ^[3]

作者单位： Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China; Institute of Breast Disease, School of Medicine, Tongji University, China. ^[1] Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China. ^[2] Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China; Institute of Breast Disease, School of Medicine, Tongji University, China. Electronic address: 1200038@tongji.edu.cn. ^[3]

关键词 Deubiquitination PD-L1 Triple-negative breast cancer USP15 VGLL4

医学主题词人类(Humans);细胞系, 肿瘤(Cell Line, Tumor);免疫疗法(Immunotherapy);抗原, 肿瘤(Antigens, Neoplasm);RNA结合蛋白质类(RNA-Binding Proteins);转录因子(Transcription Factors)

DOI 10.1016/j.canlet.2024.216764

PMID 38431034

发布时间 2025-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交